Tongue Cancer Doctors Worldwide

Specialized in radiation oncology at Marmara University – Dr. Sahibov focuses on precise treatment planning for tongue cancer.

• Trained at Marmara University Faculty of Medicine
• Specialization in radiation oncology completed in 2016
• Works at Emsey Hospital with advanced radiation therapy equipment

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Dr. Topcu has trained at prestigious cancer centers like MD Anderson and Sunnybrook Odette, specializing in head and neck cancers including tongue cancer.

• Medical oncology residency at Karadeniz Technical University
• Member of ESMO and ASCO – leading global oncology societies
• Treats a wide range of cancers with focus on complex cases
• Works at Biruni University Hospital with multidisciplinary teams

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Prof. Elke Jaeger performs 1,100 procedures annually – one of Germany's top oncologists according to Focus rating for 41 years.

• 41 years specializing in oncology and hematology
• Head of Oncology and Hematology at Nordwest Clinic
• Professor in interdisciplinary oncology at Goethe University
• Top sarcoma specialist with high case volume

Professor Kyzas leads the MANTRA trial, the largest randomized controlled trial in OMFS, and specializes in advanced tongue cancer treatments.

• Over 70 scientific papers published in high-impact journals
• Pioneer in 3D printer–personalized planning reconstructive surgery
• Certified microvascular surgeon with extensive head and neck surgery experience
• Clinical Director for cancer services covering over 1M people
• Editor in Chief of the British Journal of Oral and Maxillofacial Surgery

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Performed 50,000+ cancer surgeries – Dr. Nagarkar brings 30 years of expertise in surgical oncology to HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital – India's premier cancer center
• Specializes in Breast and Thoracic Surgical Oncology
• Conducted 200+ clinical trials for new cancer treatments
• Professor for DNB Superspecialty Surgical Oncology

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. López-Ibor specializes in pediatric oncology with over 32 years of experience, currently leading the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital.

• Expert in treating bone and brain tumors in children
• Specialized in Pediatric Hematology and Oncology at the University of Maryland
• Author of numerous national and international scientific publications

Dr. Manish Kumar is a surgical oncologist at SilverStreak Multispecialty Hospital in Gurgaon. He treats head and neck oncology, including oral, thyroid, and laryngeal cancers. Dr. Kumar received the Lala Kotu Ram Memorial Oration Award for his work in ENT and head and neck surgery. He works at a JCI-accredited facility.

• Performs oral cancer resections with microvascular free flap reconstruction.
• Treats larynx cancer using voice rehabilitation, including TEP prosthesis and esophageal speech.
• Uses intraoperative nerve monitoring during thyroid and parathyroid surgeries.
• Uses transoral laser systems and harmonic scalpel technology for tumor removal.

Dr. María José Morán Soto is an oral, head, and neck surgeon at Publio Cordón Memorial Hospital in Madrid. She performs oncological surgery for cancers of the tongue, tonsils, larynx, and thyroid. Dr. Morán Soto conducts complex reconstructive procedures for functional recovery after tumor removal. The hospital is a JCI-accredited facility in Spain with a staff of over 110 specialists.

Dr. Antonio Fernández García is a maxillofacial and head and neck surgeon at Publio Cordón Memorial Hospital in Madrid. He specializes in surgical oncology and reconstructive surgery.

He treats head and neck cancers, including larynx, tongue, and tonsil cancer. The hospital holds JCI accreditation for safety and quality standards.